Literature DB >> 31724816

Novel variants in FERMT3 and RASGRP2-Genetic linkage in Glanzmann-like bleeding disorders.

Georgi Manukjan1, Verena A Wiegering2, Tobias Reindl3, Gabriele Strauß3,4, Eva Klopocki5, Harald Schulze1,6, Oliver Andres2,6.   

Abstract

Defects of platelet intracellular signaling can result in severe platelet dysfunction. Several mutations in each of the linked genes FERMT3 and RASGRP2 on chromosome 11 causing a Glanzmann-like bleeding phenotype have been identified so far. We report on novel variants in two unrelated pediatric patients with severe bleeding diathesis-one with leukocyte adhesion deficiency type III due to a homozygous frameshift in FERMT3 and the other with homozygous variants in both, FERMT3 and RASGRP2. We focus on the challenging genetic and functional variant assessment and aim to accentuate the risk of obtaining misleading results due to the phenomenon of genetic linkage.
© 2019 The Authors. Pediatric Blood & Cancer Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  bleeding disorders other than hemophilia; hematology; hemostasis and thrombosis; platelet disorders

Mesh:

Substances:

Year:  2019        PMID: 31724816     DOI: 10.1002/pbc.28078

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  2 in total

1.  CalDAG-GEFI Deficiency in a Family with Symptomatic Heterozygous and Homozygous Carriers of a Likely Pathogenic Variant in RASGRP2.

Authors:  Sara Morais; Mónica Pereira; Catarina Lau; Ana Gonçalves; Catarina Monteiro; Marta Gonçalves; Jorge Oliveira; Lurdes Moreira; Eugénia Cruz; Rosário Santos; Margarida Lima
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

Review 2.  RasGRP2 Structure, Function and Genetic Variants in Platelet Pathophysiology.

Authors:  Matthias Canault; Marie-Christine Alessi
Journal:  Int J Mol Sci       Date:  2020-02-06       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.